Cinclus Pharma is a research based biotech company.
Cinclus Pharma has raised $9.2M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2026.
Cinclus Pharma's investors include Trill Impact, Claret Capital Partners, EIR Ventures, Fourth Swedish National Pension Fund, Irrus Investments.
Cinclus Pharma is headquartered in Mölndal, Sweden.
Cinclus Pharma is a research based biotech company.
Cinclus Pharma is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cinclus Pharma — Funding & Investors." VCBacked, March 13, 2026, https://www.vcbacked.co/company/cinclus-pharma. Accessed October 6, 2026.
VCBacked. (2026). Cinclus Pharma — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/cinclus-pharma
{{cite web |title=Cinclus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/cinclus-pharma |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated